Fibrogen_US_Primary_logo_RGB_M01.jpg
FibroGen Reports Second Quarter 2023 Financial Results
August 07, 2023 16:01 ET | FibroGen, Inc.
Topline data from three late-stage pamrevlumab trials expected through 1H 2024, including the Pancreatic Cancer Action Network (PanCAN) Precision PromiseSM Phase 2/3 study in metastatic pancreatic...
Fibrogen_US_Primary_logo_RGB_M01.jpg
FibroGen to Report Fourth Quarter and Full Year 2022 Financial Results
February 17, 2023 07:00 ET | FibroGen, Inc.
SAN FRANCISCO, Feb. 17, 2023 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce its fourth quarter and full year 2022 financial results on Monday, February 27 after the market close....
Fibrogen_US_Primary_logo_RGB_M01.jpg
FibroGen to Participate at Bank of America 2022 Biotech SMID Cap Virtual Conference
November 28, 2022 07:00 ET | FibroGen, Inc.
SAN FRANCISCO, Nov. 28, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Enrique Conterno, Chief Executive Officer, will participate in a fireside chat at the Bank of...
GTDC Launches Global Anti-Bribery and Anti-Corruption Platform
April 07, 2014 09:00 ET | Global Technology Distribution Council
ST. PETERSBURG, FL--(Marketwired - Apr 7, 2014) - The Global Technology Distribution Council (GTDC) today announced that it has launched an anti-bribery and anti-corruption (ABAC) due diligence...